英文原著

1. Hirai H, Satoh H, Kudoh A, Watanabe T. Interaction between resistin and adiponectin in the proliferation of rat vascular smooth muscle cells. Mol Cell Endocrinol 2013;366(1):108-16. pubmed

2. Hirata Y, Kurobe H, Higashida M, Fukuda D, Shimabukuro M, Tanaka K, Higashikuni Y, Kitagawa T, Sata M. HMGB1 plays a critical role in vascular inflammation and lesion formation via toll-like receptor 9. Atherosclerosis 2013;231(2):227-33. pubmed

3. Hirata Y, Kurobe H, Nishio C, Tanaka K, Fukuda D, Uematsu E, Nishimoto S, Soeki T, Harada N, Sakaue H, Kitagawa T, Shimabukuro M, Nakaya Y, Sata M. Exendin-4, a glucagon-like peptide-1 receptor agonist, attenuates neointimal hyperplasia after vascular injury. Eur J Pharmacol 2013;699(1-3):106-11. pubmed

4. Hirata Y, Kurobe H, Uematsu E, Yagi S, Soeki T, Yamada H, Fukuda D, Shimabukuro M, Nakayama M, Matsumoto K, Sakai Y, Kitagawa T, Sata M. Beneficial effect of a synthetic prostacyclin agonist, ONO-1301, in rat autoimmune myocarditis model. Eur J Pharmacol 2013;699(1-3):81-7. pubmed

5. Kurobe H, Hirata Y, Matsuoka Y, Sugasawa N, Higashida M, Nakayama T, Maxfield MW, Yoshida Y, Shimabukuro M, Kitagawa T, Sata M. Protective effects of selective mineralocorticoid receptor antagonist against aortic aneurysm progression in a novel murine model. J Surg Res 2013;185(1):455-62. pubmed

6. Nakayama T, Kurobe H, Sugasawa N, Kinoshita H, Higashida M, Matsuoka Y, Yoshida Y, Hirata Y, Sakata M, Maxfield MW, Shimabukuro M, Takahama Y, Sata M, Tamaki T, Kitagawa T, Tomita S. Role of macrophage-derived hypoxia-inducible factor (HIF)-1alpha as a mediator of vascular remodelling. Cardiovasc Res 2013;99(4):705-15. pubmed

7. Shimabukuro M, Higa M, Yamakawa K, Masuzaki H, Sata M. Miglitol, alpha-glycosidase inhibitor, reduces visceral fat accumulation and cardiovascular risk factors in subjects with the metabolic syndrome: a randomized comparable study. Int J Cardiol 2013;167(5):2108-13. pubmed

8. Shimabukuro M, Higa N, Tagawa T, Yamakawa K, Sata M, Ueda S. Defects of vascular nitric oxide bioavailability in subjects with impaired glucose tolerance: a potential link to insulin resistance. Int J Cardiol 2013;167(1):298-300. pubmed

9. Shimabukuro M, Hirata Y, Tabata M, Dagvasumberel M, Sato H, Kurobe H, Fukuda D, Soeki T, Kitagawa T, Takanashi S, Sata M. Epicardial adipose tissue volume and adipocytokine imbalance are strongly linked to human coronary atherosclerosis. Arterioscler Thromb Vasc Biol 2013;33(5):1077-84. pubmed

10. Soeki T, Niki T, Uematsu E, Bando S, Matsuura T, Kusunose K, Ise T, Ueda Y, Tomita N, Yamaguchi K, Koshiba K, Yagi S, Fukuda D, Taketani Y, Iwase T, Yamada H, Wakatsuki T, Akaike M, Shimabukuro M, Kishimoto I, Kangawa K, Sata M. Ghrelin protects the heart against ischemia-induced arrhythmias by preserving connexin-43 protein. Heart Vessels 2013;28(6):795-801. pubmed

11. Taira S, Shimabukuro M, Higa M, Yabiku K, Kozuka C, Ueda R, Sunagawa S, Ohshiro Y, Doi M, Nanba T, Kawamoto E, Nakayama Y, Nakamura H, Iha T, Nakachi S, Tomoyose T, Ikema T, Yamakawa K, Masuzaki H. Lipid deposition in various sites of the skeletal muscles and liver exhibits a positive correlation with visceral fat accumulation in middle-aged Japanese men with metabolic syndrome. Intern Med 2013;52(14):1561-71. pubmed

12. Tian Z, Miyata K, Tazume H, Sakaguchi H, Kadomatsu T, Horio E, Takahashi O, Komohara Y, Araki K, Hirata Y, Tabata M, Takanashi S, Takeya M, Hao H, Shimabukuro M, Sata M, Kawasuji M, Oike Y. Perivascular adipose tissue-secreted angiopoietin-like protein 2 (Angptl2) accelerates neointimal hyperplasia after endovascular injury. J Mol Cell Cardiol 2013;57:1-12. pubmed

和文総説

1. 八木秀介, 福田大受, 添木武, 島袋充生, 佐田政隆. RAS研究-ラボの最前線- 徳島大学大学院ヘルスバイオサイエンス研究部 循環器内科学・心臓血管病態医学. Angiotension Research 2013;10:59-63.

2. 島袋充生, 佐田政隆. 【異所性脂肪-糖尿病診療における新しい視点】 異所性脂肪と2型糖尿病 異所性脂肪と心臓血管病. 糖尿病の最新治療 2013;4(4):202-208.

3. 島袋充生, Munkhbaatar D, 石田昌義, 松本幸子, 小塚智沙代, 平良伸一郎, et al. 【生活の質(QOL:Quality of life)を高める医療最前線-難治な病気に光明が見えた!-】 異所性脂肪と2型糖尿病・心臓血管病. 四国医学雑誌 2013;69(1-2):21-28.

4. 島袋充生. 【糖尿病における心腎連関】 病態 血管不全の関与. 月刊糖尿病 2013;5(11):37-45.

5. 島袋充生. 【「脂肪酸」に強くなる】 脂肪酸受容体. ホルモンと臨床 2013;61(7):513-517.

6. 島袋充生. 【糖尿病と心疾患-基礎と臨床-】 糖尿病と心臓病の基礎 心臓における糖・脂質代謝. 月刊糖尿病 2013;5(2):6-13.

7. 益崎裕章, 島袋充生. 【肥満症-病態・診断・治療-】 診断・疫学・治療 沖縄クライシスの現状と新たなチャレンジ. 最新医学 2013;68(1):98-104.